Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Clinical trial NCT03630081 · UNKNOWN

Trial details

NCT number: NCT03630081
Sponsor: Wockhardt
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Complicated Urinary Tract Infection Acute Pyelonephritis

Start date: 2024-01-01
Primary completion: 2026-01-01
Enrollment: 1004

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.